SAVA Cassava Sciences, Inc.

Cassava Sciences, Inc. is a biopharmaceutical company that develops novel drugs.

$23.93  +0.40 (1.70%)
As of 03/23/2023 15:59:55 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/11/2000
Outstanding shares:  41,749,435
Average volume:  756,413
Market cap:   $982,364,206
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJVLKZ9

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%